Sergio Traversa

Affiliations

  • Chief Executive Officer at Relmada Therapeutics Inc. (RLMD), 2025-05-20
  • Director at Actinium Pharmaceuticals Inc. (ATNM), 2017-03-16
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RLMD $0.56 147,686 $82,246.33 734,024 2025-05-20 Filing
RLMD $0.50 30,000 $14,994.00 586,338 2025-05-19 Filing
RLMD $0.45 172,314 $77,472.37 556,338 2025-05-16 Filing
RLMD $2.99 51,407 $153,706.93 384,024 2024-09-11 Filing
RLMD $2.75 33,014 $90,788.50 332,617 2024-09-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RLMD $18.32 4,068 $74,525.76 88,774 2022-07-01 Filing
RLMD $18.45 8,848 $163,245.60 92,842 2022-07-01 Filing
RLMD $18.48 839 $15,504.72 101,690 2022-07-01 Filing
RLMD $19.01 10,698 $203,368.98 88,774 2022-06-30 Filing
RLMD $19.37 5,314 $102,932.18 99,472 2022-06-30 Filing